AzTrials
AzTrials

Osteoarthritis of ShoulderTSANCT06154694

Glenohumeral Joint Contract Patterns in Osteoarthritic Glenoids

An observational study of Osteoarthritis of Shoulder, run by Universitaire Ziekenhuizen KU Leuven at 1 site in Belgium.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record

Search all trials

Trial summary

Shoulder osteoarthritis (OA) is a frequent problem in our aging population and is believed to occur in up to 20% of the population. Different types of glenoid morphology are associated with shoulder OA, depending on the amount and localization of the glenoid erosion as well as the amount and direction of Humeral Head… Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Osteoarthritis of Shoulder
What is being tested?
Stereo Radiographic EOS Measurements
Type of treatment
Surgery or procedure
How many people
156 participants
Where
1 siteBelgium
Study dates
3 Nov 2021to 1 Jul 2050
Phase
Observational

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Both OA patients and Healthy control group are screened in UZ Leuven for the prospective part of this study. Revised TSA patients because of glonoid component loosening are screened for the retrospective part of the study.

Who may be able to join

  • OA patients group
  • Patients with glenohumeral osteoarthritis planned for anatomic shoulder arthroplasty in the University Hospitals Leuven, Belgium
  • Complete patient informed consent
  • Pain free at the time of EOS imaging
  • Healthy control group
  • Healthy adult volunteers with no history of shoulder pain or trauma
Show all 11Show fewer
  • Confirmation of the physician, that subject's clinical evaluation and CT scan did not show any abnormalities
  • Complete informed consent
  • Revised TSA group
  • Patients with glenohumeral osteoarthritis who received an anatomic shoulder arthroplasty at the University Hospitals Leuven within the past 30 years, and who have been revised for loosening of the glenoid component.
  • At least 1 postoperative CT scan available

Who cannot join

  • Only patients with a functional TSA will be included, so patients with postoperative stiffness, pain, instability or pseudoparalysis will be excluded.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Belgium1 site, 1 recruiting
  • UZ Leuven

    Leuven, Vlaams-Brabant, 3000

    Filip Verhaegen, +3216338827, filip.verhaegen@uzleuven.be

    Philippe Debeer, +3216338837, philippe.debeer@uzleuven.be

    Recruiting

Other trials in Belgium

About this study

Official title: In-vivo Evaluation of Glenohumeral Joint Contact Patterns in Osteoarthritic Glenoids

Shoulder osteoarthritis (OA) is a frequent problem in our aging population and is believed to occur in up to 20% of the population. Different types of glenoid morphology are associated with shoulder OA, depending on the amount and localization of the glenoid erosion as well as the amount and direction of Humeral Head Migration.

Total shoulder arthroplasty (TSA) has been shown to relieve the pain and improve joint function of patients with OA. However, several complications such as component loosening and polyethylene damage has been reported and it has been revealed that 7.3% of glenoids may show signs of asymptomatic radiographic loosening annually after primary anatomic TSA. The mechanism of such fixation failure is still unclear.

The main goal of this study is evaluating in-vivo glenohumeral contact patterns in patients with osteoarthritic glenoids before and after TSA, to unravel the high rate of glenoid component loosening.

Read the detailed description

Shoulder osteoarthritis (OA) is a frequent problem in our aging population and is believed to occur in up to 20% of the population. OA leads to pain, restriction of movement and functional disability. Furthermore, chronic instability, characterized by humeral head migration (HHM), and pathologic changes of the glenoid bone, i.e. glenoid erosions, is common in OA. Different types of glenoid morphology are associated with shoulder OA, depending on the amount and localization of the glenoid erosion as well as the amount and direction of HHM. On the basis of these factors glenoids are classified in A, B, C and D types 4. In this classification A glenoid is a centered or symmetric arthritis without posterior subluxation of the humeral head. The B glenoid is characterized by asymmetric bone erosion, leading to glenoid retroversion, combined with posterior HHM. The D glenoid is defined by glenoid anteversion or anterior humeral head subluxation, while C glenoid is a dysplastic glenoid with at least 25° of retroversion "not caused by erosion.

Total shoulder arthroplasty (TSA) has been shown to relieve the pain and improve joint function of patients with OA. However, several complications such as component loosening and polyethylene damage has been reported and it has been revealed that 7.3% of glenoids may show signs of asymptomatic radiographic loosening annually after primary anatomic TSA. Although, aberrant glenohumeral contact mechanics has been suggested to be one of the primary potential causes, the mechanism of such fixation failure is still unclear. Glenohumeral conformity, eccentric loads associated with shoulder instability, bone quality, cementing techniques, implant orientation and design are all confounding factors that indeed affect the mechanical environment of the glenoid component, and, more specifically, also in terms of the contact mechanics.

Knowledge of in vivo glenohumeral joint contact mechanics before and after total shoulder arthroplasty and its interplay with patient- and surgery-related parameters may unravel the high rate of glenoid component loosening in patients with osteoarthritic glenoids and provide insight for the improvement of patient function, implant designs, implant longevity, and surgical technique. Previous ex-vivo and computational modelling studies that focused on the glenohumeral contact area after TSA, suggested that arm elevation in the scapular plane results in aberrant posterior translation of the humeral head in TSA patients. However, an in-vivo study based on dual-plane fluoroscopy, demonstrated that this only occurs in 50% of TSA patients. These discrepancies could arise from analyzing an assorted population of TSA patients without taking into account any specific information with regards to their preoperative osseous and soft-tissue status such as type of glenoid erosion, degree of glenoid retroversion, and amount of rotator cuff degeneration. Postoperative factors such as degree of retroversion correction, amount of joint-line medialization and glenohumeral components' radial mismatch were also not considered in these studies.

The main goal of this study is evaluating in-vivo glenohumeral contact patterns in patients with osteoarthritic glenoids before and after TSA, to unravel the high rate of glenoid component loosening. To that aim, the project is divided into four sub-objectives. The first objective is to compare glenohumeral contact areas before and after surgery in patients with osteoarthritic glenoids, using EOS (micro-dose x-ray) stereo radiographic imaging, to evaluate whether osseous correction during surgery is able to correct glenohumeral joint kinematics. The second objective is to compare OA patient's glenohumeral contact areas before and after surgery with healthy subjects. The third objective is to identifying variations in glenohumeral contact patterns after surgery with respect to the pre-and postoperative state of the patients. The last objective is to evaluate the influence of the location of the glenohumeral contact area after surgery on the long-term outcome and survival of the glenoid component.

The total study population will consist of 3 main groups: 1) a healthy control group, 2) a group of OA patients with different types of osteoarthritic glenoids (A, B, C and D glenoids) scheduled for TSA, 3) and a retrospectively included group of TSA patients who have been revised due to loosening of the glenoid component.

Being tested
Stereo Radiographic EOS Measurements

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Stereo Radiographic EOS MeasurementsRadiation

    Healthy control will undergo a stereo radiographic EOS exam with their arm in various positions.

    1. Relaxed standing (0 degree of abduction)
    2. 45 degree of abduction in the coronal plane
    3. 90 degree of abduction in the coronal plane
    4. 120 degree of abduction in the coronal plane
    5. 45 degree anterior flexion in the sagittal plane
    6. 90 degree anterior flexion in the sagittal plane
    7. 120 degree of anterior flexion in the sagittal plane
    8. 45 degree extension in the sagittal plane
Study groups in NCT06154694
Study groupRoleWhat they receive
Shoulder osteoarthritis patients (prospective)Patients with glenohumeral osteoarthritis with different types of osteoarthritic glenoids (A, B, C and D glenoids) scheduled for Total shoulder arthroplasty (TSA)
Receives: Radiation: Stereo Radiographic EOS Measurements
Healthy control group (prospective)Healthy adult volunteers with no history of shoulder pain or trauma
Receives: Radiation: Stereo Radiographic EOS Measurements
Revision of glenoid component (retrospective)Retrospectively included group of Total shoulder arthroplasty (TSA) patients who have been revised due to loosening of the glenoid component

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Compere In-vivo glenohumeral joint contact patterns in patients using EOS stereo radiographic imaging

    Evaluating in-vivo glenohumeral joint contact patterns in patients with different type of osteoarthritic glenoids pre- and post-TSA. Glenohumeral contact areas are compared before and after surgery in patients with osteoarthritic glenoids, using EOS stereo radiographic imaging

    Measured: 2 years

  2. Compere in-vivo glenohumeral joint contact patterns in healthy subjects using EOS stereo radiographic imaging

    Evaluating glenohumeral joint contact patterns in healthy subjects and comparing them with patients with osteoarthritic glenoids before patients receive surgery and after patients receive surgery. Glenohumeral contact areas are compared using EOS stereo radiographic imaging

    Measured: 2 years

  3. Pre-operative factor: Humeral Head Migration

    Identifying probable pre-operative factors; for example the amount of HHM; on glenohumeral contact area after surgery using pre- and postoperative CT scans.

    Measured: 2 years

  4. Pre-operative factor: Inclination and rotator cuff muscle's quality

    Identifying probable pre-operative factors; for example the inclination and rotator cuff muscle's quality; on glenohumeral contact area after surgery using pre- and postoperative CT scans.

    Measured: 2 years

  5. Pre-operative factor: Degree of glenoid version

    Identifying probable pre-operative factors; for example the degree of glenoid version; on glenohumeral contact area after surgery using pre- and postoperative CT scans.

    Measured: 2 years

  6. Intra-operative factors: Degree of glenoid orientation correction

    Identifying probable intra-operative factors; for example the degree of glenoid orientation correction; on glenohumeral contact area after surgery.

    Measured: 2 years

  7. Intra-operative factors: Joint-line medialization

    Identifying probable intra-operative factors; for example the joint-line medialization; on glenohumeral contact area after surgery.

    Measured: 2 years

  8. Amount of osteolysis inside the glenoid vault and around glenoid component

    Evaluating the amount of osteolysis inside the glenoid vault and around glenoid component of the patients at least 2 years after surgery

    Measured: 2 years

Secondary outcomes (2)
  1. Variations in glenohumeral contact areas

    Determining possible variations in glenohumeral contact areas among patients with different type of osteoarthritic glenoids (A, B, C and D glenoids).

    Measured: 2 years

  2. Influence of the location of the glenohumeral contact pattern

    Evaluate the influence of the location of the glenohumeral contact area and amount of their deviations from healthy subjects on the long-term outcome and survival of the glenoid component. Pre-operative and 2 years after surgery, a CT scan from OA group will be obtained , which will be used for evaluating long-term outcome and survival of the glenoid component .

    Measured: 2 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Dec 2023
  2. Study start3 Nov 2021
  3. Primary completion1 Jul 2050 (estimated)
  4. Study completion1 Jul 2050 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Other
Enrolment
156 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06154694
Sponsor's protocol ID
S64986
Acronym
TSA
Status last verified
Mar 2026
First submitted
31 Oct 2023
Last updated
2 Apr 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in